Anticonvulsant drug actions on GABA responses and sustained repetitive firing of neurons in cell culture
dc.contributor.author | Macdonald, Robert L. | en_US |
dc.contributor.author | Skerritt, John H. | en_US |
dc.contributor.author | McLean, Michael J. | en_US |
dc.date.accessioned | 2006-04-07T18:26:25Z | |
dc.date.available | 2006-04-07T18:26:25Z | |
dc.date.issued | 1984-07 | en_US |
dc.identifier.citation | Macdonald, Robert L., Skerritt, John H., McLean, Michael J. (1984/07)."Anticonvulsant drug actions on GABA responses and sustained repetitive firing of neurons in cell culture." Neuropharmacology 23(7, Part 2): 843-844. <http://hdl.handle.net/2027.42/24773> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0C-47RSK4N-J/2/618381f9dd75a8f6a77acd1b40ff7488 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24773 | |
dc.description.abstract | We have studied barbiturate, benzodiazepine (BDZ), [beta]-carboline, triazolopyridazine, piperazine carboxylate, hydantoin, iminostilbene, valproate, and succinmide actions on GABA responses and sustained, high frequency repititive firing of mouse neurons in cell culture. Barbiturates, clinically used BDZ, zopiclone and C1 218,872 enhanced GABA responses. Ro 15-1788 and propyl-[beta]-carboline were partial agonists at BDZ receptors while DMCM was an inverse agonist. Phenytoin, carbamazepine, phenobarbital, diazepam and valproic acid limited sustained repetitive firing. We suggest that enhancement of GABAergic inhibition and limitation of sustained high frequency repetitive firing may be anticonvulsant mechanisms of action. | en_US |
dc.format.extent | 195943 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Anticonvulsant drug actions on GABA responses and sustained repetitive firing of neurons in cell culture | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24773/1/0000197.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0028-3908(84)90275-2 | en_US |
dc.identifier.source | Neuropharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.